Inventor
DENK OLIVER
DE9 patents
Patents
9 patentsUS10857198B2Dec 8, 2020
Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
BREATH THERAPEUTICS GMBH2 citations71
US11419819B2Aug 23, 2022
Inhalable compositions for use in the treatment of pulmonary diseases
BREATH THERAPEUTICS GMBH2 citations69
US11701403B2Jul 18, 2023
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
BREATH THERAPEUTICS GMBH1 citations67
US11484566B2Nov 1, 2022
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
BREATH THERAPEUTICS GMBH4 citations67
US11744872B2Sep 5, 2023
Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
BREATH THERAPEUTICS GMBH0 citations60
US12263247B2Apr 1, 2025
Inhalable compositions for use in the treatment of pulmonary diseases
BREATH THERAPEUTICS GMBH0 citations59
US11890376B2Feb 6, 2024
Inhalable compositions for use in the treatment of pulmonary diseases
BREATH THERAPEUTICS GMBH0 citations59
US12178843B2Dec 31, 2024
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
BREATH THERAPEUTICS GMBH0 citations56
US12303593B2May 20, 2025
Inhalable compositions comprising macrocyclic immunosuppressants
BREATH THERAPEUTICS GMBH0 citations48